1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Blood and immune system conditions
  5. Blood and bone marrow cancers

Daratumumab monotherapy for treating relapsed and refractory multiple myeloma

Technology appraisal guidance [TA783] Published: 13 April 2022

  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

Tools and resources

Tools to help you put the guidance into practice.

Resource impact

  • Resource impact report PDF 209 KB 13 April 2022  
  • Resource impact template Excel 1.26 MB 13 April 2022  

Guidance into practice

  • About the Into practice guide  
  • Practical steps to improving the quality of care and services using NICE guidance